An exploratory study: The use of paroxetine for methamphetamine craving

Melissa P. Piasecki, Gerri M. Steinagel, Ole J Thienhaus, Barbara S. Kohlenberg

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Methamphetamine abuse and dependence are growing problems nationally and worldwide. There are currently no effective pharmocologic treatments. Animal studies with SSRI's suggest that serotonergic modulation alters methamphetamine's behavioral effects. This exploratory study is a trial of the effects of the SSRI paroxetine versus placebo (in a double blind design) on craving and use in a population of methamphetamine users. Many subjects dropped out of the study, but those in active treatment who completed the eight week trial had a decrease in methamphetamine craving compared to the placebo treatment as measured by the OCDS modified for use in this population. Statistical analyses were not performed due to the low number of subjects. The preliminary data suggest that serotonergic agents may play a role in the effective treatment of methamphetamine abuse and dependence within the context of other effective behavioral interventions.

Original languageEnglish (US)
Pages (from-to)301-304
Number of pages4
JournalJournal of Psychoactive Drugs
Volume34
Issue number3
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Paroxetine
Methamphetamine
Placebos
Serotonin Agents
Therapeutics
Population
Craving

Keywords

  • Craving
  • Methamphetamine
  • OCDS
  • SSRI

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Psychology(all)
  • Clinical Psychology

Cite this

Piasecki, M. P., Steinagel, G. M., Thienhaus, O. J., & Kohlenberg, B. S. (2002). An exploratory study: The use of paroxetine for methamphetamine craving. Journal of Psychoactive Drugs, 34(3), 301-304.

An exploratory study : The use of paroxetine for methamphetamine craving. / Piasecki, Melissa P.; Steinagel, Gerri M.; Thienhaus, Ole J; Kohlenberg, Barbara S.

In: Journal of Psychoactive Drugs, Vol. 34, No. 3, 07.2002, p. 301-304.

Research output: Contribution to journalArticle

Piasecki, MP, Steinagel, GM, Thienhaus, OJ & Kohlenberg, BS 2002, 'An exploratory study: The use of paroxetine for methamphetamine craving', Journal of Psychoactive Drugs, vol. 34, no. 3, pp. 301-304.
Piasecki, Melissa P. ; Steinagel, Gerri M. ; Thienhaus, Ole J ; Kohlenberg, Barbara S. / An exploratory study : The use of paroxetine for methamphetamine craving. In: Journal of Psychoactive Drugs. 2002 ; Vol. 34, No. 3. pp. 301-304.
@article{4dc3007369de4871ab0c673cd1b89ab5,
title = "An exploratory study: The use of paroxetine for methamphetamine craving",
abstract = "Methamphetamine abuse and dependence are growing problems nationally and worldwide. There are currently no effective pharmocologic treatments. Animal studies with SSRI's suggest that serotonergic modulation alters methamphetamine's behavioral effects. This exploratory study is a trial of the effects of the SSRI paroxetine versus placebo (in a double blind design) on craving and use in a population of methamphetamine users. Many subjects dropped out of the study, but those in active treatment who completed the eight week trial had a decrease in methamphetamine craving compared to the placebo treatment as measured by the OCDS modified for use in this population. Statistical analyses were not performed due to the low number of subjects. The preliminary data suggest that serotonergic agents may play a role in the effective treatment of methamphetamine abuse and dependence within the context of other effective behavioral interventions.",
keywords = "Craving, Methamphetamine, OCDS, SSRI",
author = "Piasecki, {Melissa P.} and Steinagel, {Gerri M.} and Thienhaus, {Ole J} and Kohlenberg, {Barbara S.}",
year = "2002",
month = "7",
language = "English (US)",
volume = "34",
pages = "301--304",
journal = "Journal of Psychoactive Drugs",
issn = "0279-1072",
publisher = "Haight-Ashbury Publications",
number = "3",

}

TY - JOUR

T1 - An exploratory study

T2 - The use of paroxetine for methamphetamine craving

AU - Piasecki, Melissa P.

AU - Steinagel, Gerri M.

AU - Thienhaus, Ole J

AU - Kohlenberg, Barbara S.

PY - 2002/7

Y1 - 2002/7

N2 - Methamphetamine abuse and dependence are growing problems nationally and worldwide. There are currently no effective pharmocologic treatments. Animal studies with SSRI's suggest that serotonergic modulation alters methamphetamine's behavioral effects. This exploratory study is a trial of the effects of the SSRI paroxetine versus placebo (in a double blind design) on craving and use in a population of methamphetamine users. Many subjects dropped out of the study, but those in active treatment who completed the eight week trial had a decrease in methamphetamine craving compared to the placebo treatment as measured by the OCDS modified for use in this population. Statistical analyses were not performed due to the low number of subjects. The preliminary data suggest that serotonergic agents may play a role in the effective treatment of methamphetamine abuse and dependence within the context of other effective behavioral interventions.

AB - Methamphetamine abuse and dependence are growing problems nationally and worldwide. There are currently no effective pharmocologic treatments. Animal studies with SSRI's suggest that serotonergic modulation alters methamphetamine's behavioral effects. This exploratory study is a trial of the effects of the SSRI paroxetine versus placebo (in a double blind design) on craving and use in a population of methamphetamine users. Many subjects dropped out of the study, but those in active treatment who completed the eight week trial had a decrease in methamphetamine craving compared to the placebo treatment as measured by the OCDS modified for use in this population. Statistical analyses were not performed due to the low number of subjects. The preliminary data suggest that serotonergic agents may play a role in the effective treatment of methamphetamine abuse and dependence within the context of other effective behavioral interventions.

KW - Craving

KW - Methamphetamine

KW - OCDS

KW - SSRI

UR - http://www.scopus.com/inward/record.url?scp=0036660929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036660929&partnerID=8YFLogxK

M3 - Article

C2 - 12422941

AN - SCOPUS:0036660929

VL - 34

SP - 301

EP - 304

JO - Journal of Psychoactive Drugs

JF - Journal of Psychoactive Drugs

SN - 0279-1072

IS - 3

ER -